Training in the Molecular Biology of Neurodegeneration

神经退行性变分子生物学培训

• 批准号: 6454495
• 负责人: Bruce A YANKNER
• 金额: $ 62.56万
• 依托单位: HARVARD MEDICAL SCHOOL
• 依托单位国家: 美国
• 财政年份: 1992
• 资助国家: 美国
• 起止时间: 1992-09-30 至 2007-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6454495
• 关键词: Training; Molecular; Biology; Neurodegeneration

DESCRIPTION (provided by applicant): We propose to continue a highly successful inter-departmental and inter-institutional Training Program in the Molecular Biology of Neurodegeneration - a program devoted to the training of pre- and postdoctoral students for careers as independent research scientists in universities and health-related research laboratories. The trainers are all Harvard faculty with active research programs in Alzheimer's disease and other neurodegenerative disorders related to aging. They are drawn from the Harvard Medical School and five affiliated research hospitals: Beth Israel-Deaconess Hospital, Brigham and Women's Hospital, Children's Hospital, Massachusetts General Hospital, and McLean Hospital. Bringing a wide range of experience and experimental approaches to the problems of age-related neurodegeneration, the Program faculty include molecular biologists, geneticists, cell biologists, neuropathologists, and biochemists. The pre-doctoral students are recruited into and drawn from the graduate students in the degree-granting Neuroscience Program of the Harvard Medical School. The postdoctoral students are chosen from among applicants nominated by individual faculty members of the Program. A total of six pre-doctoral trainees and eight postdoctoral trainees is proposed for a primary training faculty of 31 individuals experienced in basic and applied studies of age-related neurodegeneration. In all cases, the main criteria for successful candidates is dedication and interest in aging and neurodegeneration research and the highest level of academic achievement in their previous training. All students are required to participate in special neurodegeneration courses and seminars. The purpose of the Program is to create a framework within which the best training of future researchers devoted to problems in aging and neurodegeneration can take place and the already extensive interactions among the Program faculty can be continued.

描述（由申请人提供）：我们建议继续高度 成功实施跨部门和跨机构培训计划 神经退行性疾病的分子生物学-一个致力于培训的程序， 作为独立研究科学家的博士前和博士后学生 在大学和与健康有关的研究实验室。教练们都是 哈佛教师积极开展阿尔茨海默病和阿尔茨海默病的研究项目 其他与衰老有关的神经退行性疾病。它们来自 哈佛医学院和五个附属研究医院：贝丝 以色列女执事医院、布里格姆妇女医院、儿童医院、 马萨诸塞州总医院和姆克林医院。带来了广泛的 与年龄有关的问题的经验和实验方法 神经变性，该计划的教师包括分子生物学家， 遗传学家、细胞生物学家、神经病理学家和生物化学家。 博士预科生从研究生中招收和抽取 哈佛医学院授予学位的神经科学项目的学生 学校博士后学生从提名的申请人中选择 由该计划的个别教师组成。共有六名博士预科生 培训生和8名博士后培训生拟进行初级培训 教师31个人在基础和应用研究经验丰富， 与年龄有关的神经退化在所有情况下，成功的主要标准 候选人对衰老和神经退行性疾病研究的奉献精神和兴趣 以及他们之前训练中的最高学术成就。所有 学生必须参加特殊的神经变性课程， 研讨会等该方案的目的是建立一个框架， 对未来致力于老龄化问题的研究人员进行最好的培训， 神经退行性变可以发生，并且已经广泛的相互作用， 该计划的教师可以继续。